STEROIDOGENIC ACTIVITY OF HIGH MOLECULAR-WEIGHT FORMS OF CORTICOTROPIN

The high molecular weight forms of adrenocorticotropic hormone (ACTH) produced by mouse pituitary tumor cells (AtT-20/D-16v) were separated from each other by gel filtration; their ability to stimulate steroidogenesis by isolated rat adrenal cortical cells was studied. Pools of pro-ACTH/endorphin, ACTH biosynthetic intermediate, and glycosylated ACTH(l-39) were obtained; on the basis of NaDodSO4-polyacrylamide gel electrophoresis, over 97% of the immunoactive ACTH was found to have the expected molecular weight. Suspensions of isolated rat adrenal cortical cells were incubated overnight in tissue culture medium and used in a 2-h steroid production assay. Synthetic human ACTH(l-39) [hACTH(l-39)] was used as a bioassay and immunoassay standard; 60 pM hACTH(l-39) stimulated half-maximal production of fluorogenic steroid. The amount of pro-ACTH/endorphin, ACTH biosynthetic intermediate, or glycosylated ACTH(l-39) added was estimated with an ACTH( 17-24) immunoassay. All three high molecular weight forms of ACTH are capable of stimulating the same maximallevel of steroidogenesis as hACTH(l-39). Glycosylated ACTH(l-39) is equipotent with hACTH(l-39); ACTH biosynthetic intermediate and pro-ACTH/endorphin are, respectively, 100- and 300-fold less potent than hACTH(l-39). Steroid production in response to all four forms of ACTH is linear in time. All of the different forms of ACTH stimulate the synthesis of corticosterone and related steroids; no significant production of Cortisol or aldosterone was observed. β-Lipotropin (βLPH) and 16K fragment, which comprise the non-ACTH regions of pro-ACTH/endorphin and are secreted by the pituitary tumor cells, did not stimulate or interfere with steroidogenesis. Brief incubations of pro-ACTH/endorphin and ACTH biosynthetic intermediate with trypsin generated lower molecular weight forms of ACTH and increased biological activity 50-fold; thus, the decreased steroidogenic potency of these forms of ACTH is thought to be due to structural constraints on the ACTH(l-39)-like sequence in these larger precursor molecules. © 1979, American Chemical Society. All rights reserved.